52 HIGH-DENSITY LIPOPROTEIN MODULATES OXIDIZED PHOSPHOLIPID SIGNALING IN ENDOTHELIAL CELLS FROM PROINFLAMMATORY TO ANTI-INFLAMMATORY. Issue 1 (1st January 2007)
- Record Type:
- Journal Article
- Title:
- 52 HIGH-DENSITY LIPOPROTEIN MODULATES OXIDIZED PHOSPHOLIPID SIGNALING IN ENDOTHELIAL CELLS FROM PROINFLAMMATORY TO ANTI-INFLAMMATORY. Issue 1 (1st January 2007)
- Main Title:
- 52 HIGH-DENSITY LIPOPROTEIN MODULATES OXIDIZED PHOSPHOLIPID SIGNALING IN ENDOTHELIAL CELLS FROM PROINFLAMMATORY TO ANTI-INFLAMMATORY.
- Authors:
- Gharavi, N. M.
Gargalovic, P. S.
Chang, I.
Araujo, J.
Watson, A. D.
Lusis, A. J.
Berliner, J. A. - Abstract:
- Abstract : Oxidized 1-palmitoyl-2-arachidonyl- sn -3-glycero-phosphorylcholine (Ox-PAPC) and its component phospholipid, 1-palmitoyl-2-(5, 6 epoxyisoprostanoyl)- sn -glycero-3-phosphocholine (PEIPC), which are present in atherosclerotic lesions, activate endothelial cells (EC) to induce a complex inflammatory response. Previously, we demonstrated induction of genes regulating chemotaxis, sterol biosynthesis, the unfolded protein response, and redox homeostasis by Ox-PAPC in human aortic EC (HAEC). Activation of the c-Src kinase/STAT3 pathway and the endothelial nitric oxide synthase (eNOS)/sterol regulatory element binding protein (SREBP) pathway were shown to regulate several of these inflammatory effects of Ox-PAPC in HAEC. High-density lipoprotein (HDL) has anti-inflammatory and antioxidant properties. The goal of the current studies was to determine the role of HDL in regulating Ox-PAPC signaling in HAEC. Using quantitative real-time PCR and Western analysis, we demonstrated that pretreatment of HAEC with HDL for 1 hour, followed by cotreatment, reduced the induction of chemotactic, sterol biosynthetic and UPR genes, by Ox-PAPC and PEIPC. Furthermore, treatment with HDL inhibited the activation of c-Src kinase, STAT3, and SREBP and reversed the uncoupling of eNOS triggered by Ox-PAPC. Finally, we demonstrated that treatment with HDL did not inhibit Ox-PAPC and PEIPC activation of redox pathways, which protect the cell from the effects of oxidative stress. Taken together,Abstract : Oxidized 1-palmitoyl-2-arachidonyl- sn -3-glycero-phosphorylcholine (Ox-PAPC) and its component phospholipid, 1-palmitoyl-2-(5, 6 epoxyisoprostanoyl)- sn -glycero-3-phosphocholine (PEIPC), which are present in atherosclerotic lesions, activate endothelial cells (EC) to induce a complex inflammatory response. Previously, we demonstrated induction of genes regulating chemotaxis, sterol biosynthesis, the unfolded protein response, and redox homeostasis by Ox-PAPC in human aortic EC (HAEC). Activation of the c-Src kinase/STAT3 pathway and the endothelial nitric oxide synthase (eNOS)/sterol regulatory element binding protein (SREBP) pathway were shown to regulate several of these inflammatory effects of Ox-PAPC in HAEC. High-density lipoprotein (HDL) has anti-inflammatory and antioxidant properties. The goal of the current studies was to determine the role of HDL in regulating Ox-PAPC signaling in HAEC. Using quantitative real-time PCR and Western analysis, we demonstrated that pretreatment of HAEC with HDL for 1 hour, followed by cotreatment, reduced the induction of chemotactic, sterol biosynthetic and UPR genes, by Ox-PAPC and PEIPC. Furthermore, treatment with HDL inhibited the activation of c-Src kinase, STAT3, and SREBP and reversed the uncoupling of eNOS triggered by Ox-PAPC. Finally, we demonstrated that treatment with HDL did not inhibit Ox-PAPC and PEIPC activation of redox pathways, which protect the cell from the effects of oxidative stress. Taken together, these studies demonstrated that HDL inhibits the proinflammatory effects of Ox-PAPC and PEIPC while maintaining the antioxidant activities of these oxidized lipids. … (more)
- Is Part Of:
- Journal of investigative medicine. Volume 55:Issue 1(2007)
- Journal:
- Journal of investigative medicine
- Issue:
- Volume 55:Issue 1(2007)
- Issue Display:
- Volume 55, Issue 1 (2007)
- Year:
- 2007
- Volume:
- 55
- Issue:
- 1
- Issue Sort Value:
- 2007-0055-0001-0000
- Page Start:
- S84
- Page End:
- S84
- Publication Date:
- 2007-01-01
- Subjects:
- Clinical medicine -- Periodicals
Medicine -- Research -- Periodicals
Medicine
Research -- United States
Clinical medicine
Medicine -- Research
Periodicals
616.075 - Journal URLs:
- http://journals.lww.com/jinvestigativemed/pages/default.aspx ↗
http://jim.bmj.com/ ↗
https://journals.sagepub.com/home/IMJ ↗
http://journals.lww.com ↗ - Languages:
- English
- ISSNs:
- 1081-5589
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5008.010000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 17618.xml